Frequently Asked Questions
Factors such as growing emphasis on research and development in the fields of molecular diagnostics are the major growth driving factors.
Abbott (U.S.), QIAGEN N.V. (Germany), Agilent Technologies Inc. (U.S.), Bayer AG (Germany), Rubicon Genomics (U.S.), BD (U.S.), F. Hoffmann-La Roche AG (Switzerland), Digene Corporation (U.S.), bioMérieux (France), Bio-Rad Laboratories, Inc. (U.S.), Cepheid (U.S.) and Takara Bio, Inc. (Japan) are the major companies operating in this market.
North America dominates the gene amplification detector devices market due to the rising investments in healthcare infrastructures, technological advancements, and the availability of government funds.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the favourable government initiative towards the advancement of healthcare infrastructure.
